Australian Clinical Labs Statistics
Total Valuation
ASX:ACL has a market cap or net worth of AUD 509.50 million. The enterprise value is 778.39 million.
Market Cap | 509.50M |
Enterprise Value | 778.39M |
Important Dates
The last earnings date was Tuesday, August 26, 2025.
Earnings Date | Aug 26, 2025 |
Ex-Dividend Date | Sep 1, 2025 |
Share Statistics
ASX:ACL has 194.47 million shares outstanding. The number of shares has decreased by -4.64% in one year.
Current Share Class | 194.47M |
Shares Outstanding | 194.47M |
Shares Change (YoY) | -4.64% |
Shares Change (QoQ) | -11.47% |
Owned by Insiders (%) | 2.25% |
Owned by Institutions (%) | 82.84% |
Float | 187.05M |
Valuation Ratios
The trailing PE ratio is 15.37 and the forward PE ratio is 13.61. ASX:ACL's PEG ratio is 0.96.
PE Ratio | 15.37 |
Forward PE | 13.61 |
PS Ratio | 0.69 |
PB Ratio | 2.96 |
P/TBV Ratio | 82.91 |
P/FCF Ratio | 2.92 |
P/OCF Ratio | 2.79 |
PEG Ratio | 0.96 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 3.81, with an EV/FCF ratio of 4.46.
EV / Earnings | 24.00 |
EV / Sales | 1.05 |
EV / EBITDA | 3.81 |
EV / EBIT | 11.45 |
EV / FCF | 4.46 |
Financial Position
The company has a current ratio of 0.55, with a Debt / Equity ratio of 1.69.
Current Ratio | 0.55 |
Quick Ratio | 0.44 |
Debt / Equity | 1.69 |
Debt / EBITDA | 1.42 |
Debt / FCF | 1.67 |
Interest Coverage | 4.66 |
Financial Efficiency
Return on equity (ROE) is 18.77% and return on invested capital (ROIC) is 8.96%.
Return on Equity (ROE) | 18.77% |
Return on Assets (ROA) | 7.28% |
Return on Invested Capital (ROIC) | 8.96% |
Return on Capital Employed (ROCE) | 18.97% |
Revenue Per Employee | 157,717 |
Profits Per Employee | 6,900 |
Employee Count | 4,700 |
Asset Turnover | 1.27 |
Inventory Turnover | 28.99 |
Taxes
In the past 12 months, ASX:ACL has paid 15.36 million in taxes.
Income Tax | 15.36M |
Effective Tax Rate | 31.88% |
Stock Price Statistics
The stock price has decreased by -18.38% in the last 52 weeks. The beta is 1.07, so ASX:ACL's price volatility has been similar to the market average.
Beta (5Y) | 1.07 |
52-Week Price Change | -18.38% |
50-Day Moving Average | 2.75 |
200-Day Moving Average | 3.10 |
Relative Strength Index (RSI) | 44.09 |
Average Volume (20 Days) | 1,532,619 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ASX:ACL had revenue of AUD 741.27 million and earned 32.43 million in profits. Earnings per share was 0.17.
Revenue | 741.27M |
Gross Profit | 270.86M |
Operating Income | 68.00M |
Pretax Income | 48.18M |
Net Income | 32.43M |
EBITDA | 81.36M |
EBIT | 68.00M |
Earnings Per Share (EPS) | 0.17 |
Balance Sheet
The company has 22.12 million in cash and 290.38 million in debt, giving a net cash position of -268.26 million or -1.38 per share.
Cash & Cash Equivalents | 22.12M |
Total Debt | 290.38M |
Net Cash | -268.26M |
Net Cash Per Share | -1.38 |
Equity (Book Value) | 171.98M |
Book Value Per Share | 0.88 |
Working Capital | -96.34M |
Cash Flow
In the last 12 months, operating cash flow was 182.80 million and capital expenditures -8.41 million, giving a free cash flow of 174.39 million.
Operating Cash Flow | 182.80M |
Capital Expenditures | -8.41M |
Free Cash Flow | 174.39M |
FCF Per Share | 0.90 |
Margins
Gross margin is 36.54%, with operating and profit margins of 9.17% and 4.37%.
Gross Margin | 36.54% |
Operating Margin | 9.17% |
Pretax Margin | 6.50% |
Profit Margin | 4.37% |
EBITDA Margin | 10.98% |
EBIT Margin | 9.17% |
FCF Margin | 23.53% |
Dividends & Yields
This stock pays an annual dividend of 0.13, which amounts to a dividend yield of 4.81%.
Dividend Per Share | 0.13 |
Dividend Yield | 4.81% |
Dividend Growth (YoY) | 4.17% |
Years of Dividend Growth | n/a |
Payout Ratio | 76.92% |
Buyback Yield | 4.64% |
Shareholder Yield | 9.44% |
Earnings Yield | 6.37% |
FCF Yield | 34.23% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
ASX:ACL has an Altman Z-Score of 2.5 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.5 |
Piotroski F-Score | 7 |